This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Psychiatry  • Attention Deficit Hyperactivity Disorder  • Alert me on articles by topic

JAMA. 2005;294:2293-2296.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2005;54:842-847

2 figures, 1 table omitted

Attention-deficit/hyperactivity disorder (ADHD), previously known as attention deficit disorder, is a neurobehavioral disorder characterized by pervasive inattention and hyperactivity-impulsivity that often results in substantial functional impairment (see sidebar). Prevalence estimates of ADHD in school-aged children have ranged from 2% to 18% in community samples.¹ Although stimulant medications are an effective first-line treatment for ADHD,² concern persists regarding the possible side effects and long-term health outcomes associated with stimulant consumption.¹ Estimating the number of children who have had ADHD diagnosed and are currently taking medication for the disorder is an important step toward understanding the overall burden of ADHD in the United States. Previously, population-based estimates of medication treatment for ADHD were not available or were limited by their lack of generalizability.^3-5 To estimate rates of parent-reported ADHD diagnosis and medication treatment for ADHD, CDC analyzed data from the 2003 National Survey of Children’s . . . [Full Text of this Article]

Reported by: